Brineura approved for rare genetic illness affecting kids
(HealthDay)—Brineura (cerliponase alfa) has been approved by the U.S. Food and Drug Administration to treat a specific form of Batten Disease, a rare set of genetic disorders that typically begin in childhood between ages ...
Apr 28, 2017
0
2